|
Index of reports
> Cases resulting in a serious event (741)
> Cases with Breast Cancer (264)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in a serious event where reactions include breast cancer.
Reports 1 - 25 of 264 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2002-03-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer, Lung Neoplasm Malignant, Myocardial Infarction, Cerebrovascular Accident
Suspect drug(s):
Estrogen NOS
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 59 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 59 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Adverse event in 52 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 52 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 59 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 59 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 52 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 52 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 62 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 62 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 53 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-01-01
End date: 2001-06-01
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-01-01
End date: 2001-06-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female, weighing 737.8 kg (1623.1 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 72 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 72 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Adverse event in 55 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 55 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 56 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1995-01-01
Page 1 Next >>
|
